Literature DB >> 26243822

Cystoid macular edema associated with chemotherapy.

Rajesh C Rao1, Netan Choudhry2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26243822      PMCID: PMC4754186          DOI: 10.1503/cmaj.131080

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Cystoid macular edema secondary to albumin-bound paclitaxel therapy.

Authors:  Stacy V Smith; Matthew S Benz; David M Brown
Journal:  Arch Ophthalmol       Date:  2008-11

2.  Topical dorzolamide therapy for taxane-related macular oedema.

Authors:  J P Ehlers; H Rayess; N Steinle
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

3.  Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.

Authors:  William J Gradishar; Sergei Tjulandin; Neville Davidson; Heather Shaw; Neil Desai; Paul Bhar; Michael Hawkins; Joyce O'Shaughnessy
Journal:  J Clin Oncol       Date:  2005-09-19       Impact factor: 44.544

4.  Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy.

Authors:  Ehsan Rahimy; David Sarraf
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2013-02-19       Impact factor: 1.300

5.  Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.

Authors:  Hassan T Rahman; Steven Yeh; Chris S Bergstrom
Journal:  J Ocul Pharmacol Ther       Date:  2012-10-12       Impact factor: 2.671

  5 in total
  2 in total

1.  Intravitreal Ranibizumab Had Limited Effect on Cystoid Macular Edema Due to Albumin-Bound Paclitaxel: A Case Report and Literature Review.

Authors:  Suna Ye; Qiqi Fang; Jinyu Yao; Jianqiang Xing; Shibo Tang; Jacey Hongjie Ma
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

2.  Loratadine-associated cystoid macular edema: A case report.

Authors:  Yong Tang; Rui Dou; Yuyan Liu; Shiyong Xie; Quanhong Han
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.